Fingerprint
Dive into the research topics of 'Alemtuzumab (Campath 1H) as Successful Salvage Therapy for Recurrent Steroid-resistant Heart Transplant Rejection'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Alemtuzumab (Campath 1H) as Successful Salvage Therapy for Recurrent Steroid-resistant Heart Transplant Rejection
Kenneth J. Woodside, Scott D. Lick
Research output: Contribution to journal › Article › peer-review
19
Scopus
citations